sanofi
Monticello / Shutterstock
6 June 2023FeaturesBig PharmaMuireann Bolger

Sanofi v Amgen antibody case lands front of queue at UPC

The  Unified Patent Court (UPC) may be less than a week old but it is already set to be the latest stage for the long-running dispute between Sanofi and Amgen concerning antibody patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.
Big Pharma
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.

More on this story

Big Pharma
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.
Big Pharma
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.

More on this story

Big Pharma
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.
Big Pharma
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.